Skip to main content
. 2024 Sep 22;12(9):1926. doi: 10.3390/microorganisms12091926
HCV Hepatitis C virus
DAAs Direct-acting antivirals
HCC Hepatocellular carcinoma
SVR Sustained virologic response
NHL Non-Hodgkin lymphoma
OR Odds ratio
CI Confidence interval
NK Natural killer